Literature DB >> 20510050

[Risk factors which were associated with heroin use during the methadone maintenance treatment among 1301 patients in 9 cities of China.].

Xiao-bin Cao1, Wen-yuan Yin, Lin Pang, Cong-bin Zhang, Jin-shui Xu, Yong-kang Xiao, Chang-he Wang, Wei Luo, Bo Zhang, Rui-min Zhang, Zhi-jun Li, Ke-ming Rou, Zun-you Wu.   

Abstract

OBJECTIVE: To determine the proportion of heroin use among patients who were involved in community-based methadone maintenance treatment (MMT) program and to identify the risk factors associated with heroin use.
METHODS: This study was conducted in 9 MMT clinics within 3 provinces. Thirteen hundred and one patients who met the study criteria were selected from each of the five groups with different dosages of methadone users. An administrative questionnaire was applied to explore the demographics, drug abuse-related behaviors and MMT services received by the clients, etc. The prevalence of depression and anxiety among the clients were also collected by SAS and SDS. Urine samples were collected as a biological marker to indicate if heroin had been used.
RESULTS: Of the 1301 patients, 76.2% were males. The mean age was (34.6 +/- 6.5) years while 71.7% had an education level of primary school or below. The average daily dosage of methadone was (48.1 +/- 29.4) mg and self-satisfied evaluation score on treatment was 8.6. On average, 27.7% urine samples showed positive opiate evidence. Marital status, employment status, treatment retention, self-satisfied evaluation score on dosage and dropout history were found to be significantly associated with heroin use, while gender, education level and dosage had no significant association with heroin use. It seemed that risk factors that associated with heroin use were different from areas to areas.
CONCLUSION: High quality MMT clinic services, high self-satisfied score, longer treatment retention and low dropout rate seemed to have the effects of reducing the risk of ongoing heroin abuse under the methadone maintenance treatment program.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510050

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  7 in total

1.  Concurrent heroin use among methadone maintenance clients in China.

Authors:  Li Li; Chunqing Lin; Dai Wan; Linglin Zhang; Wenhong Lai
Journal:  Addict Behav       Date:  2011-11-07       Impact factor: 3.913

2.  HIV seroconversion and risk factors among drug users receiving methadone maintenance treatment in China: A qualitative study.

Authors:  Changhe Wang; Cynthia X Shi; Bo Zhang; Hong Chen; Hua Wang; Nanci Zhang; Keming Rou; Xiaobin Cao; Wei Luo; Zunyou Wu
Journal:  Drug Alcohol Depend       Date:  2016-08-21       Impact factor: 4.492

3.  Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.

Authors:  Iuliia Makarenko; Alyona Mazhnaya; Ruthanne Marcus; Iryna Pykalo; Lynn Madden; Sergii Filippovich; Sergii Dvoriak; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2018-01-11

4.  Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response.

Authors:  Tran Vu Hoang; Tran Thi Thanh Ha; Tran Minh Hoang; Nguyen To Nhu; Nguyen Cuong Quoc; Nguyen thi Minh Tam; Stephen Mills
Journal:  Harm Reduct J       Date:  2015-10-16

5.  Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China.

Authors:  Bo Zhang; Thomas Cai; Zhihua Yan; Gitau Mburu; Bangyuan Wang; Liping Yang
Journal:  Harm Reduct J       Date:  2016-02-26

6.  Positive percentages of urine morphine tests among methadone maintenance treatment clients with HIV/AIDS: a 12-month follow-up study in Guangdong Province, China.

Authors:  Xiaofeng Luo; Xiao Gong; Peizhen Zhao; Xia Zou; Wen Chen; Li Ling
Journal:  BMJ Open       Date:  2017-04-27       Impact factor: 2.692

7.  Influence of social network on drug use among clients of methadone maintenance treatment centers in Kunming, China.

Authors:  Ling Shen; Sawitri Assanangkornchai; Wei Liu; Le Cai; Fei Li; Songyuan Tang; Jiucheng Shen; Edward B McNeil; Virasakdi Chongsuvivatwong
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.